Literature DB >> 17978913

[The management of snake envenomation: evaluation of twenty-one snake bite cases].

Rüştü Köse1.   

Abstract

BACKGROUND: Snake envenomation, its treatment and outcomes are presented in this study.
METHODS: Twenty-one snake bite cases (10 males, 11 females; mean age 36.4; range 10 to 70 years) were followed up at our clinic during the summers of 2004 and 2005. Four of these patients were "dry bite". The remaining 17 cases were envenomated.
RESULTS: Local and hematological disorders were detected in envenomated cases. Local skin necrosis developed in a case. Thrombocytopenia was seen in five of the cases. Seven units of whole blood were transfused in three patients. When the Zagreb antiserum which was produced against European snakes was used, better results achieved. The serum which was imported from Egypt was given to the patient in case of lacking of Zagreb serum was lacking. Clinical conditions were improved later with the "Egypt serum" although higher doses had been administered.
CONCLUSION: Hematological disorders and local wound problems were more prominent with poisonous snake bite cases in our region. We conclude that these problems can be prevented by using antiserum treatment as early as possible.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17978913

Source DB:  PubMed          Journal:  Ulus Travma Acil Cerrahi Derg


  3 in total

1.  The management of pit viper envenomation of the hand.

Authors:  Mehmet Bozkurt; Yalcin Kulahci; Fatih Zor; Emin Kapi
Journal:  Hand (N Y)       Date:  2008-05-28

2.  Diabetic foot due to anaphylactic shock: a case report.

Authors:  Ali Karakus; Mustafa Ozkan; Murat Karcioglu; Raif Ozden; Ihsan Ustun; Koca Caliskan; Cumali Gokce; Mustafa Sahan
Journal:  Arch Trauma Res       Date:  2014-06-01

Review 3.  Current Knowledge on Snake Dry Bites.

Authors:  Manuela B Pucca; Cecilie Knudsen; Isadora S Oliveira; Charlotte Rimbault; Felipe A Cerni; Fan Hui Wen; Jacqueline Sachett; Marco A Sartim; Andreas H Laustsen; Wuelton M Monteiro
Journal:  Toxins (Basel)       Date:  2020-10-22       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.